Nestlé Wyeth Nutrition

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search

On 23 April 2012, Nestlé agreed to acquire Pfizer Inc.'s infant-nutrition, formerly Wyeth Nutrition, unit for US$11.9 billion, topping a joint bid from Danone and Mead Johnson.[1][2][3]Nestle Wyeth Nutrition provides food products to meet the needs of infants, young children and adults. Through scientific research,they claim to help nourish children when breastfeeding is not an option. Wyeth Nutrition started in 1915 when Henry Grestberger manufactured the first formula patterned after breast milk called SMA ( synthetic milk adaptive). Wyeth Pharmaceuticals, formerly Wyeth-Ayerst Laboratories, is the original company founded by the Wyeth brothers, originally known as John Wyeth and Brother. They focused on the research, development, and marketing of prescription drugs. The pharmaceuticals division was further subdivided into five subdivisions: Wyeth Research, Prescription Products, Biotech, Vaccines, and Nutritionals. Wyeth's research and development director Robert Ruffolo was quoted in The New York Times about the firm's efforts to develop new drugs.[4][5]

Notes and references[edit]

  1. ^ "Nestlé to Acquire Pfizer Baby Food Unit for $11.9 Billion". Bloomberg, 23 April 2012
  2. ^ "Mead Johnson looks tasty, but Abbott may have to pass".
  3. ^ "Nestlé to buy Pfizer Nutrition for $11.85bn". NewStatesman. Retrieved 5 January 2016.
  4. ^ Gina kolata (March 28, 2004). "Ideas & Trends: Of Mice and Men; Why Test Animals to Cure Human Depression?". The New York Times. Retrieved 2010-12-26. But Dr. Robert R. Ruffolo, president of research and development at Wyeth,...
  5. ^ Andrew pollack (June 14, 2010). "Awaiting the Genome Payoff". The New York Times. Retrieved 2010-12-26. “If on the first day we had discovered a new molecular target, it’s still going to take 15 to 20 years to make the drug,” said Robert R. Ruffolo Jr., who ran research and development at Wyeth until 2008.